Association of an RNA signature (RS) with emergence of ICOS hi CD4 T cells and efficacy outcomes for the ICOS agonist vopratelimab (vopra) and nivolumab (nivo) in patients (pts) on the ICONIC trial Meeting Abstract


Authors: Yap, T. A.; Gainor, J. F.; Burris, H. A.; Kummar, S.; Pachynski, R. K.; Callahan, M. K.; LoRusso, P.; Tykodi, S. S.; Gibney, G. T.; Falchook, G. S.; Rahma, O. E.; Seiwert, T. Y.; Papadopoulos, K. P.; Mier, J. W.; Hashambhoy-Ramsay, Y.; Felitsky, D.; Lee, D. Y.; McGrath, L.; Harvey, C.; Hooper, E.
Abstract Title: Association of an RNA signature (RS) with emergence of ICOS hi CD4 T cells and efficacy outcomes for the ICOS agonist vopratelimab (vopra) and nivolumab (nivo) in patients (pts) on the ICONIC trial
Meeting Title: 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 5 Suppl.
Meeting Dates: 2020 Feb 6-8
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-02-10
Language: English
ACCESSION: WOS:000529994300019
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.5_suppl.14
Notes: Meeting Abstract: 14 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Margaret Kathleen Callahan
    197 Callahan